Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network …

J Mutz, V Vipulananthan, B Carter, R Hurlemann… - bmj, 2019 - bmj.com
Objective To estimate the comparative clinical efficacy and acceptability of non-surgical
brain stimulation for the acute treatment of major depressive episodes in adults. Design …

Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials

S Bai, W Guo, Y Feng, H Deng, G Li, H Nie… - Journal of Neurology …, 2020 - jnnp.bmj.com
Objectives To systematically review the efficacy and safety of anti-inflammatory agents for
patients with major depressive disorders. Methods We searched the literature to identify …

Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence

J Sarris, A Panossian, I Schweitzer, C Stough… - European …, 2011 - Elsevier
Research in the area of herbal psychopharmacology has increased markedly over the past
decades. To date however, a comprehensive review of herbal antidepressant, anxiolytic and …

A brief history of the development of antidepressant drugs: from monoamines to glutamate.

TM Hillhouse, JH Porter - Experimental and clinical …, 2015 - psycnet.apa.org
Major depressive disorder (MDD) is a chronic, recurring, and debilitating mental illness that
is the most common mood disorder in the United States. It has been almost 50 years since …

Agomelatine, the first melatonergic antidepressant: discovery, characterization and development

C De Bodinat, B Guardiola-Lemaitre… - Nature reviews Drug …, 2010 - nature.com
Current management of major depression, a common and debilitating disorder with a high
social and personal cost, is far from satisfactory. All available antidepressants act through …

A systematic review of insomnia and complementary medicine

J Sarris, GJ Byrne - Sleep medicine reviews, 2011 - Elsevier
In concert with growing public interest in complementary and alternative medicine (CAM),
these therapies and products have been increasingly studied over the past two decades for …

[HTML][HTML] The effect of most important medicinal plants on two importnt psychiatric disorders (anxiety and depression)-a review

K Saki, M Bahmani, M Rafieian-Kopaei - Asian Pacific journal of tropical …, 2014 - Elsevier
Anxiety and depression are highly comorbid psychiatric conditions that the prevalence will
be increased to the second greatest risk of morbidity, causing a significant socioeconomic …

The molecular pathophysiology of depression and the new therapeutics

H Tian, Z Hu, J Xu, C Wang - MedComm, 2022 - Wiley Online Library
Major depressive disorder (MDD) is a highly prevalent and disabling disorder. Despite the
many hypotheses proposed to understand the molecular pathophysiology of depression, it is …

Sexual dysfunction, depression, and the impact of antidepressants

SH Kennedy, S Rizvi - Journal of clinical psychopharmacology, 2009 - journals.lww.com
Sexual dysfunction is a common symptom of depression. Although decreased libido is most
often reported, difficulties with arousal, resulting in vaginal dryness in women and erectile …

Ketamine and the future of rapid-acting antidepressants

LM Riggs, TD Gould - Annual Review of Clinical Psychology, 2021 - annualreviews.org
The therapeutic onset of traditional antidepressants is delayed by several weeks and many
depressed patients fail to respond to treatment altogether. In contrast, subanesthetic …